Carenostics
Carenostics provides an AI-powered administrative assistant for US hospital transplant programs, automating outside record gathering, clinical findings extraction, and EHR documentation across the full transplant workflow. The company sells enterprise SaaS subscriptions directly to health system transplant program leadership.
- Company typePrivate
- Founded2021
- HeadquartersBerwyn, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Carenostics does
Carenostics is a US-based healthcare AI company that sells an enterprise SaaS platform acting as an "administrative assistant" for hospital transplant programs. Founded in 2021 by Kanishka Rao (CEO) and Dr. Bharat Rao (President & Chief AI Officer), the company initially developed AI to identify undiagnosed and undertreated chronic diseases using electronic health record (EHR) data, then pivoted in 2023 to focus narrowly on transplant operations. The platform targets the five stages of the transplant workflow — referral intake, evaluation, waitlist management, organ acceptance, and post-transplant monitoring — and is sold through quote-based annual or multi-year subscriptions to transplant program leadership (coordinators, physicians, surgeons, administrators). The company leverages Medicare Cost Report reimbursability of pre-transplant administrative infrastructure as a key financial justification lever for buyers.
The core product is built on a SMART-on-FHIR and HL7 native EHR integration layer that requires no custom interface builds. It proactively monitors outside health systems a patient touches, automatically extracts clinically relevant findings from unstructured records (including 300+ page media manager files), and writes structured data back to the EHR. AI capabilities span process automation, knowledge retrieval, and anomaly detection. The platform is hosted on a HITRUST-certified, HIPAA-compliant cloud with SSO, RBAC, and full audit logging, and supports zero local PHI storage. All data handling is enterprise-grade (SSO, RBAC, audit trails).
Carenostics distributes exclusively through direct enterprise field sales, supported by peer-reviewed publications in journals such as ASN, AAAI, NeurIPS, CHEST, and ATS, and by conference presentations at ATS, ASN, HLTH, and PACT. The company has raised $5 million in seed funding (September 2023, led by M13 with GreatPoint Ventures, Gaingels, and Kurt Hilzinger), was the sole portfolio company of Bayer G4A in 2022, holds a partnership with AstraZeneca, and has a named customer deployment at Hackensack Meridian Health. The company operates with a small team (stated as 1–10 employees) and is based in New York.
Carenostics firmographics
Firmographics- Name
- Carenostics
- Legal name
- Carenostics Inc.
- Website
- https://carenostics.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Carenostics provides an AI-powered administrative assistant for US hospital transplant programs, automating outside record gathering, clinical findings extraction, and EHR documentation across the full transplant workflow. The company sells enterprise SaaS subscriptions directly to health system transplant program leadership.
- Ownership category
- akta.pro rank
Carenostics industry classification
Industry- Product category
- Healthcare AI Software
- NAICS
- Offices of All Other Miscellaneous Health Practitioners (621399), All Other Outpatient Care Centers (621498)
- SIC
- Services-Prepackaged Software (7372), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Care Management & Coordination Platforms (case/disease management workflows) (HLACAHAD)
- akta.pro secondary industry
- Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology) (HLALABAD)
Keywords
Where Carenostics is headquartered
LocationHeadquarters
- HQ city
- Berwyn
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Carenostics business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- SaaS Subscription (Transplant Program): Carenostics sells annual or multi-year SaaS subscriptions to hospital transplant programs. Pricing is quoted-based per program/deployment. The company leverages Medicare Cost Report reimbursability as a key financial lever — pre-transplant administrative infrastructure is reimbursable via the Medicare Cost Report, which offsets a meaningful portion of contract cost for most transplant programs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise subscription for transplant programs |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels6 records
Carenostics product offering
Product offeringCore offering
Carenostics provides an AI-powered clinical data platform that functions as an administrative assistant for hospital transplant teams. The platform proactively gathers patient records from outside health systems, automatically extracts clinically relevant findings from unstructured clinical data, and automates administrative work that is written back to the EHR as structured data across the full transplant workflow from referral through post-transplant monitoring.
Product overview
Carenostics offers a single unified AI platform as an administrative assistant for transplant teams. The platform covers five stages of the transplant workflow: Referral (complete records from day one), Evaluation (committee-ready summaries), Waitlist Management (continuous monitoring with real-time alerts), Organ Acceptance (current patient picture at decision time), and Post-Transplant Monitoring (ongoing patient tracking). The product integrates natively with major EHRs via SMART-on-FHIR and HL7 standards, automatically extracting unstructured clinical data and writing structured findings back to the EHR. The platform is described as built specifically for transplant teams, not adapted from other service lines.
Differentiator
Problem solved
Functional benefit
Products and services
- Carenostics Transplant AI Platform AI-powered administrative assistant for hospital transplant teams that proactively gathers outside patient records, automatically extracts clinically relevant findings from unstructured clinical data, and automates administrative work across the full transplant workflow (referral, evaluation, waitlist management, organ acceptance, post-transplant monitoring). Writes structured findings back to the EHR. For transplant coordinators, physicians, surgeons, and program administrators at hospitals and health systems.
Quantifiable outcome
- 30% faster time to waitlist
- +9 more outcomes
Companies that use Carenostics
Customer profileNamed customers2 records
Segments1 record
Ideal customer profiles1 record
Carenostics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability5 records
Feature6 records
Carenostics partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and flagship.
- Major EHR PartnerscoreCarenostics has integrated natively with major Electronic Health Record systems using SMART-on-FHIR and HL7 industry standards. The integration allows deployment alongside existing EHR workflows without custom interface builds.
- HITRUSTcoreHITRUST certification validates Carenostics' security posture and compliance with healthcare regulatory requirements, providing confidence to health system customers regarding data protection.
- AstraZenecacorePartnership with AstraZeneca, a major pharmaceutical company, to collaborate on chronic disease diagnosis and treatment using AI-powered analysis of electronic health records.
- Bayer G4AflagshipCarenostics was the sole portfolio company of Bayer G4A's 2022 cohort, representing a significant strategic healthcare partnership. Bayer G4A supports digital health startups developing solutions with pharmaceutical company relevance.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
Carenostics competitors and assessment
Company assessmentOthers
- Datavant: Datavant provides health data connectivity, record-linking, and de-identification across healthcare organizations. It is comparable as an enabling interoperability/data infrastructure provider whose outside-record-gathering capabilities overlap with Carenostics' core proactive outside-record feature.
Direct peers
- Cohere Health: Cohere Health applies AI/ML to clinical workflows such as prior authorization and care management for payers and providers. It is comparable as an AI-driven clinical workflow automation vendor selling into enterprise healthcare customers with similar AI capabilities (unstructured data interpretation, workflow automation).
- Qventus: Qventus is an AI-based hospital operations platform that automates discharge planning, OR utilization, and other inpatient workflows. It is comparable as an AI vendor automating administrative and clinical operations for large health systems, with a similar go-to-market into hospital leadership.
- Notable: Notable provides AI-powered intelligent automation for hospital workflows including patient intake, scheduling, and clinical documentation. It is comparable to Carenostics as a workflow-automation AI platform targeting enterprise health systems with similar integration and automation capabilities.
- Bamboo Health: Bamboo Health (formerly Appriss Insights and PatientPing) provides real-time care coordination, behavioral health, and care intelligence notifications across the care continuum. It is comparable as a care-coordination AI platform serving hospitals and health systems with workflow automation across disparate settings.
- LeanTaas: LeanTaas provides AI-powered transplant logistics, workflow, and care coordination software to transplant programs and organ procurement organizations. It is the closest direct peer to Carenostics, competing in the same transplant-specific clinical operations software category with overlapping buyer personas (transplant program leadership).
Broad incumbents
- Optum: Optum (UnitedHealth Group) operates a massive healthcare analytics, care management, and clinical workflow portfolio used by payers and providers. It is comparable as a broad incumbent that competes for healthcare AI and care management spend and could bundle workflow tools against niche vendors like Carenostics.
- Health Catalyst: Health Catalyst is a healthcare data and analytics platform serving large hospital systems with population health, quality, and operational analytics. It is comparable as a broader healthcare AI/analytics incumbent with overlapping health-system customers that could expand into transplant-specific workflow automation.
- Epic Systems: Epic Systems is the dominant EHR vendor for large US health systems and is increasingly embedding AI and automation into clinical workflows. It is comparable as the incumbent EHR platform whose workflows Carenostics integrates with and which could in theory expand native transplant functionality to disintermediate third-party vendors.
Emerging players
- Arcadia: Arcadia is a healthcare data platform providing population health management and clinical analytics to provider groups and health systems. It is comparable as an emerging healthcare data/analytics player targeting enterprise customers with workflow-adjacent capabilities that could expand into transplant operational workflows.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Carenostics social profiles
Digital presenceCarenostics compliance and trust
Trust signalCompliance2 records
Carenostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Carenostics leadership team
Management profileNumber of profiles
Profiles8 records
Carenostics funding detail
Funding detailFunding overview
Funding rounds1 record
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Carenostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Carenostics
What does Carenostics do?
Carenostics provides an AI-powered clinical data platform that functions as an administrative assistant for hospital transplant teams. The platform proactively gathers patient records from outside health systems, automatically extracts clinically relevant findings from unstructured clinical data, and automates administrative work that is written back to the EHR as structured data across the full transplant workflow from referral through post-transplant monitoring.
Is Carenostics a public or private company?
Carenostics is a private company. It is classified as venture growth investor backed and is currently operating.
When was Carenostics founded?
Carenostics was founded in 2021. It employs 1 to 10 people.
Where is Carenostics based?
Carenostics is headquartered in Berwyn, United States, in the North America region.
How does Carenostics make money?
One revenue line is on record: saaS Subscription (Transplant Program).
Who are Carenostics's main competitors?
Datavant is listed as an others. Direct peers are Cohere Health, Qventus, Notable, Bamboo Health and LeanTaas. Broad incumbents are Optum, Health Catalyst and Epic Systems. Arcadia is listed as an emerging player.
Does Carenostics have an API?
No public API is recorded for Carenostics.
What industry is Carenostics in?
Carenostics's product category is Healthcare AI Software. Its primary akta.pro industry code is HLACAHAD, Care Management & Coordination Platforms (case/disease management workflows), with a secondary code of HLALABAD, Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology). Its NAICS code is 621399 and its SIC code is 7372.